The Value of Surface Enhanced Laser Desorption/Ionization-time of Flight Mass Spectrometry at the Diagnosis of Non-small Cell Lung Cancer: a Systematic Review.

Technology in cancer research & treatment

PubMedID: 23862745

Jiang F, Zhou XY, Huang J. The Value of Surface Enhanced Laser Desorption/Ionization-time of Flight Mass Spectrometry at the Diagnosis of Non-small Cell Lung Cancer: a Systematic Review. Technol Cancer Res Treat. 2013;.
Numbers of studies used surface enhanced laser desorption/ionization-time of flight mass spectrometry (SELDI-TOF-MS) to find novel serum biomarkers for non-small cell lung cancer (NSCLC). It is arguable whether the SELDI technique has its value of diagnostic accuracy for NSCLC. The purpose of our study is to determine the diagnostic accuracy of SELDI-TOF-MS for diagnosing NSCLC. The Cochrane Central Register of Controlled Trials, MEDLINE, Pub Med, EMBASE, the Chinese Biomedical Literature Database, the China Academic Journals Full-text Database, and the Chinese Scientific Journals Database were searched systematically for potential studies. Reference lists of included studies and review articles were also reviewed. All studies that reported data on patients with a confirmed diagnosis of NSCLC and that compared the measurement of SELDI-TOF-MS with pathology standard were considered for inclusion. 11 studies were included in the systematic review. The ranges of the diagnostic value of SELDI-TOF-MS for NSCLC were as follows: sensitivity (SEN) was 0.70˜1.00; specificity (SPE) was 0.68˜1.00; positive likelihood ratio (PLR) was 2.23˜23.14; negative likelihood ratio (NLR) was 0.04˜0.43; and diagnostic odds ratio (DOR) was 5.17˜621.0, respectively. SELDI-TOF-MS showed high accuracy in identifying NSCLC, and could be a potential screening tool for diagnosing NSCLC patients.